The relationship of copper to DNA damage and damage prevention in humans

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 733, Issue 1-2, 2012, Pages 83-91

  Linder, Maria C ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Cancer; Cancer and neurological diseases; Chromatin; Copper; Diseases of copper accumulation; DNA; DNA and chromatin damage; Neurological diseases; Nutritional biochemistry of copper; Nutritional biochemistry); Reactive oxygen species

Indexed keywords

COPPER; REACTIVE OXYGEN METABOLITE;

ACETYLATION; ALZHEIMER DISEASE; CARCINOGENESIS; CELL CULTURE; CHROMATIN; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DNA BINDING; DNA CROSS LINKING; DNA DAMAGE; DNA METHYLATION; DOUBLE STRANDED DNA BREAK; EPIGENETICS; GENOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SINGLE STRANDED DNA BREAK; WILSON DISEASE;

CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN; COPPER; DNA DAMAGE; FOOD; HEPATOLENTICULAR DEGENERATION; HUMANS; MUTAGENS; NERVOUS SYSTEM DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

MAMMALIA;

EID: 84860569809     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2012.03.010     Document Type: Review

References (76)

1. Linder M.C. Nutritional biochemistry of copper, with emphasis on the perinatal period. Biochemical Aspects of Human Nutrition 2010, 143-179. Transworld Research Network, Trivandrum, Kerala, India. L. Avigliano, L. Rossi (Eds.).
2. Lutsenko S. Human copper homeostasis: a network of interconnected pathways. Curr. Opin. Chem. Biol. 2010, 14:211-217.
3. Puig S., Thiele D.J. Molecular mechanisms of copper uptake and distribution. Curr. Opin. Chem. Biol. 2002, 6:171-180.
4. Linder M.C. Copper and genomic stability. Mutation Res. 2001, 475:141-152.
5. Ralle M., Huster D., Vogt S., Schirrmeister W., Burkhead J.L., Capps T.R., Gray L., Lai B., Maryon E., Lutsenko S. Wilson disease at a single cell level. Intracellular copper trafficking activates compartment-specific responses in hepatocytes. J. Biol. Chem. 2010, 285:30875-30883.
6. Kamunde C., MacPhail R. Subcellular interactions of dietary cadmium, copper and zinc in rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2011, 105:518-527.
7. Linder M.C. Biochemistry of Copper 1991, Plenum, New York.
8. Dijkwel P.A., Weningk P.W. Structural integrity of the nuclear matrix: differential effects of thiol agents and metal chelators. J. Cell Sci. 1986, 84:53-67.
9. Burkitt M.J. Copper-DNA adducts. Methods Enzymol. 1994, 234:66-79.
10. 2. J. Biol. Chem. 1991, 266:20185-20191.
11. Hanif S., Shamim U., Ullah M.F., Azmi A.S., Bhat S.H., Hadi S.M. The anthocyanidin delphinidin mobilizes endogenous copper ions from human lymphocytes leading to oxidative degradation of cellular DNA. Toxicology 2008, 249:19-25.
12. Shamim U., Hanif S., Ullah M.F., Azmi A.S., Bhat S.H., Hadi S.M. Plant polyphenols mobilize nuclear copper in human peripheral lymphocytes leading to oxidatively generated DNA breakage: implications for an anticancer mechanism. Free Rad. Res. 2008, 42:764-772.
13. Hadi S.M., Ullah M.F., Azmi A.S., Ahmed A., Shamim U., Zubair H., Khan H.Y. Resveratrol mobilizes endogenous copper in human peripheral lymhocytes leading to oxidative DNA breakage: a putative mechanism form chemoprevention of cancer. Pharm. Res. 2010, 27:979-988.
14. Wang H.-F., Chuang S.-M., Hsiao C.-C., Cherng S.-H. The synergistic effect of GABA tea and copper(II) on DNA breakage in human peripheral lymphocytes. Food Chem. Toxicol. 2011, 49:955-962.
15. Buchtik R., Travnicek Z., Vanco J., Herchel R., Dvorak Z. Synthesis, charaterixation, DNA interaction and cleavage, and in vitro cytotoxicity of copper(II) mixed ligand complexes with 2-phenyl-3-hydroxy-4(1H)-quinolinone. Dalton Trans. 2011, 40:9404-9412.
16. 2, and calf thymus DNA. J. Biol. Inorg. Chem. 2010, 15:515-532.
17. Cao H., Wang Y. Quantification of oxidative single-base and intrastrand cross-link lesions in unmethylated and CpG-methylated DNA induced by Fenton-type reagents. Nucleic Acids Res. 2007, 35:4833-4844.
18. Bar-Or D., Thomas G.W., Rael L.T., Lau E.P., Winkler J.V. Asp-Ala-His-Lys (DAHK) inhibits copper-induced oxidative DNA double strand breaks and telomere shortening. Biochem. Biophys. Res. Commun. 2001, 282:356-360.
19. Goswami T.K., Chakravarthi B.V.S.K., Roy M., Karande A.A., Chakravarty A.R. Ferrocene-conjugated l-tryptophan copper(II) complexes of phenanthroline bases showing DNA photocleavage activity and cytotoxicity. Inorg. Chem. 2011, 50:8452-8464.
20. Tawa R., Takami M., Imakura Y., Lee K.H., Sakurai H. Breaks in double-strand DNA by Cu(II) complexes of etoposide (VP-16) and its derivatives, as evaluated by S1 nuclease treatment. Biol. Pharm. Bull. 1997, 20:1002-1005.
21. Zeich D., Franco R., Pappa A., Panayiotidis M.I. Reactive Oxygen Species (ROS) - induced genetic and epigenetic alterations in human carcinogenesis. Mut. Res. 2011, 711:167-173.
22. Fragou D., Fragou A., Kouidou S., Njou S., Kovats L. Epigenetic mechanisms in metal toxicity (Review). Toxicol. Mech. Methods 2011, 21:343-352.
23. Tang W.Y., Ho S.M. Epigenetic reprogramming and imprinting in origins of disease. Rev. Endocr. Metab. Disord. 2007, 8:173-182.
24. 2+-induced human hepatoma cell apoptosis. J. Biol. Inorg. Chem. 2005, 10:190-198.
25. Lin C., Kang J., Zheng R. Oxidative stress is involved in inhibition of copper on histone acetylation in cells. Chem. Biol. Interact. 2005, 151:167-176.
26. Chen J., Du C., Kang J., Wang J. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis. Chem. Biol. Interact. 2008, 171:26-36.
27. Tudek B., Winczura A., Janik J., Siomek A., Foksinski M., Olinski R. Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am. J. Transl. Res. 2010, 2:254-284.
28. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
29. Duesberg P., Li R., Fabarius A., Hehlmann R. Aneuploidy and cancer: from correlation to causation. Contrib. Microbiol. 2006, 13:16-44.
30. Duesberg P., Mandrioli D., McCormack A., Nicholson J.M. Is carcinogenesis a form of speciation. Cell Cycle 2011, 10:2100-2114.
31. Balch C., Montgomery J.S., Paik H.-I., Kim S., Huang T.H.-M., Nephew K.P. New anti-cancer strategies: epigenetic therapies and biomarkers. Front. Biosci. 2005, 10:1831-1897.
32. Theophanides T., Anastassopoulou J. Copper and carcinogenesis. Crit. Rev. Oncol./Hematol. 2002, 42:57-64.
33. Stewart D.J., Issa J.-P., Kurzrock R., Nunez M.I., Jelinek J., Hong D., Oki Y., Guo Z., Gupta S., Wistuba I.I. Decitabine effect on tumor global DNA methylation and other parameters in a phase 1 trial in refractory solid tumors and lymphomas. Clin. Cancer Res. 2009, 15:3881-3888.
34. Banas A., Kwiatek W.M., Zajac W. Trace element analysis of tissue section by means of synchrotron radiation: the use of GNUPLOT for SRIXE spectra analysis. J. Alloys Compd. 2001, 328:135-138.
35. Dobrowolski Z., Drewniak T., Kwiatek W., Jakubik P. Trace elements distribution in renal cell carcinoma depending on stage of disease. Eur. Urol. 2002, 42:475-480.
36. Davis C., Newman S. Inadequate dietary copper increases tumorigenesis in the Min mouse. Cancer Lett. 2001, 159:57-62.
37. Khan G., Merajver S. Copper chelation in cancer therapy using tetrathiomolybdate: an evolving program. Expert Opin. Investig. Drugs 2009, 18:541-548.
38. Brewer G.J., Dick R.D., Grover D.K., LeClaire V., Tseng M., Wicha M., Pienta K., Redman B.G., Jahan T., Sondak V.K., Strawderman M., LeCarpentier G., Merajver S.D. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangeogenic agent: Phase I study. Clin Cancer Res. 2000, 6:1-10.
39. Kumar P., Yadav A., Patel S.N., Islam M., Pan Q., Merajver S.D., Teknos T.N. Tetrathiomolbydate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis. Mol. Cancer 2010, 9:206.
40. Joimel U., Gest C., Soria J., Pritchard J., Alexandre J., Laurent M., Blot E., Cazin L., Vannier J.P., Varin R., Li H., Soria C. Stimulation of angeogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate. BMC Cancer 2010, 10:375.
41. Koto K.S., Lescault P., Brard L., Kim K., Singh R.K., Bond J., Illenye S., Slavik M.A., Ashikaga T., Saulnier Sholler G.L. Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma. Int. J. Oncol. 2011, 38:1329-1341.
42. Burkhead J.L., Gray L.W., Lutsenko S. Systems biology approach to Wilsons's disease. Biometals 2011, 24:455-466.
43. Gupta A., Lutsenko S. Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med. Chem. 2009, 1:1125-1142.
44. La Fontaine S., Ackland M.L., Mercer J.F. Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: emerging roles. Int. J. Biochem. Cell Biol. 2010, 42:206-209.
45. Goode C.A. Copper and disease. Biochemistry of Copper 1991, 331-366. Plenum, New York. M.C. Linder (Ed.).
46. Ferenci P. Wilson's disease. Clin. Gastroenterol. Hepatol. 2005, 3:726-733.
47. Armendariz A.D., Gonzalez M., Loguinov A.L., Vulpe C.D. Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. Physiol. Genomics 2004, 20:45-54.
48. Du T., La Fontaine S.L., Abdo M., Ellingha S.A.B., Greenough M., et al. Investigating copper-regulated protein expression in Menkes fibroblasts using antibody microarrays. Proteomics 2008, 8:1819-1831.
49. Gross J.B., Myers B.M., Kost L.J., Kuntz S.M., LaRusso N.F. Biliary copper excretion by hepatic lysosomes in the rat. Major excretory pathway in experimental copper overload. J. Clin. Invest. 1989, 83:30-39.
50. Ebara M., Fukuda H., Hatano R., Saisho H., Nagato Y., Suzuki K., Nakajima K., Yukawa M., Kondo F., Nakayama A., Sakurai H. Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. J. Hepatol. 2000, 33:415-422.
51. Ebara M., Fukuda H., Hatano R., Yoshikawa M., Sugiura N., Saisho J., Kondo F., Yukawa M. Metal contents in the liver of patients with chronic liver disease caused by hepatitis C virus, reference to hepatocellular carcinoma. Oncology 2003, 65:323-330.
52. Fieten H., Leegater P.A.J., Watson A.L., Ruthuizen J. Canine models of copper toxicosis for understanding mammalian copper metabolism. Mamm. Genome 2011, (published online 07 December).
53. Vazquez M.C., del Pozo T., Robledo F.A., Carrasco G., Pavez L., Olivares F., Gonzalez M., Zanlungo S. Alteration of gene expression profile in Niemann-Pick Type C mice correlates with tissue damage and oxidative stress. PLos ONE 2011, 6:e28777.
54. M.C. Vazquez, P. Martinez, A.R. Alvarez, M. Gonzalez, S. Zanlungo, Increased copper levels in in vitro and in vivo models of Niemann-Pick C disease, Biometals, in press.
55. Yanagimoto C., Harada M., Kumemura H., Koga H., Kawaguchi T., Terada K., Hanada S., Taniguchi E., Koizumi Y., Koyota S., Ninomiya H., Ueno T., Sugiyama T., Sata M. Niemann-Pick C1 protein transports copper to the secretory compartment from late endosomes where AP7B resides. Exp. Cell Res. 2009, 315:119-126.
56. Yanagimoto C., Harada M., Kumemura H., Abe M., Koga H., Sakata M., Kawaguchi T., Terada K., Hanada S., Taniguchi E., Ninomiya H., Ueno T., Sugiyama T., Sata M. Copper incorporation into ceruloplasmin is regulated by Niemann-Pick C1 protein. Hepatol. Res. 2011, 41:484-491.
57. Brown D.R. Metalloproteins and neuronal death. Metallonomics 2010, 2:186-194.
58. Lutsenko S., Bhattacharjee A., Hubbard A.L. Copper handling machinery of the brain. Metallomics 2010, 2:596-608.
59. Duce J.A., Tsatsanis A., Cater M.A., James S.A., Robb E., Wikhe K., Leong S.L., Perez K., Johanssen T., Greenough M.A., Cho H.H., Galatis D., Moir R.D., Masters C.L., McLean C., Tanzi R.E., Cappai R., Barnham K.J., Ciccotosto G.D., Rogers J.T., Bush A.I. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 2010, 142:857-867.
60. Manso Y., Comes G., Hidalgo J., Bush A.I., Adlard P.A. Copper modulation as a therapy for Alzheimer's disease?. Int. J. Alzheimer's Dis. 2011, article ID 370345.
61. Kong G.K., Miles L.A., Crespi G.A., Morton C.J., Ng H.L., Barnham K.J., McKinstry W.J., Cappai R., Parkat M.W. Copper binding to the Alzheimer's disease amyloid precursor protein. Eur. Biophys. J. 2008, 37:269-279.
62. Varela-Nallar L., Toledo E.M., Larrondo L.F., Cabral A.L.B., Martins V.R., Inestrosa N.C. Induction of cellular prion protein gene expression by copper in neurons. Am. J. Physiol. (Cell Physiol.) 2006, 290:C271-C281.
63. Miura T., Sasaki S., Toyama A., Takeuchi H. Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake. Biochemistry 2005, 44:8712-8720.
64. Davies P., Brown D.R. The chemistry of copper binding to PrP: is there sufficient evidence to elucidate a role for copper in protein function?. Biochem. J. 2008, 410:237-244.
65. Viles J.H., Klewpatinond M., Nadal R.C. Copper and the structural biology of the prion protein. Biochem. Soc. Trans. 2008, 36:1288-1292.
66. Davies P., Wang X., Sarell C.J., Drewett A., Marken F., Viles J.H., Brown D.R. The synucleins are a family of redox-active copper binding proteins. Biochemistry 2011, 50:37-47.
67. Davies P., Moualla D., Brown D.R. Alpha-synuclein is a cellular ferroxidase. PLos ONE 2011, 6:e15814.
68. Wright J.A., Wang X., Brown D.R. Unique copper-induced oligomers mediate alpha-synuclein toxicity. FASEB J. 2009, 23:2384-2392.
69. Linder M.C., Roboz M. Turnover and excretion of copper in rats as measured with 67Cu. Am. J. Physiol. 1986, 251:E551-E555.
70. Turnlund J.R., Keyes W.R., Anderson H.L., Acord L.L. Copper absorption and retention in young men at three levels of dietary copper using the stable isotope, 65Cu. Am. J. Clin. Nutr. 1989, 49:870-878.
71. 65Cu. Biometals 2008, 21:525-543.
72. Bar-Or D., McDonald M.C., Thiemermann C. Reduction of infarct size in a rat model of regional myocardial ischemia and reperfusion by the synthetic peptide DAHK. Crit. Care Med. 2006, 34:1955-1959.
73. Chevion M., Jiang Y., Har-El R., Ed Berenshtein, Uretzky G., Kitrossky N. Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:1102-1106.
74. Berenshtein E., Mayer B., Goldberg C., Kitrossky N., Chevion M. Patterns of mobilization of copper and iron following ischemia: possible predictive criteria for tissue injury. J. Mol. Cell. Cardiol. 1997, 29:3025-3034.
75. Du T., Caragounis A., Parker S.J., Meyerowitz J., La Fontaine S., Kanninen K.M., Perreau V.M., Crouch P.J., White A.R. A potential copper-regulatory role for cytosolic expression of the DNA repair protein XRCC5. Free Radic. Biol. Med. 2011, 51:2060-2072.
76. Desoize B. Metals and metal compounds in carcinogenesis. In vivo 2003, 17:529-540.